Fianlimab (Anti-LAG3 / CD223)

Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.

• Supplier: Selleck Chemicals
• Product #: A2995
• Sku #: A2995-1mg